← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Thrombodyne, Inc.
Salt Lake City, UT
$8,362,538
Total funding
8
Grants
Funding over time
peak $997.9K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,362,538 · 8
By mechanism
R44$7,268,473 · 3
R43$1,094,065 · 5
Investigators at Thrombodyne, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
HARVESTING AUTOLOGOUS PLATELETS FOR WOUND HEALING$997,892
R44 · FY2009 · AG
HARVESTING AUTOLOGOUS PLATELETS FOR WOUND HEALING$987,010
R44 · FY2008 · AG
NOVEL POINT-OF-CARE PLATELET FUNCTION ANALYZER$979,404
R44 · FY2005 · HL
HARVESTING AUTOLOGOUS PLATELETS FOR WOUND HEALING$957,029
R44 · FY2010 · AG
A NOVEL POINT-OF-CARE PLATELET FUNCTION ANALYZER$956,997
R44 · FY2006 · HL
A NOVEL POINT-OF-CARE PLATELET FUNCTION ANALYZER$891,227
R44 · FY2007 · HL
ALTERNATIVE TO HEPARIN ANTICOAGULATION$461,036
R44 · FY2004 · HL
ANTIMICROBIAL TECHNOLOGY TO ACTIVELY MITIGATE HYDROCEPHALUS SHUNT INFECTIONS LONG TERM$388,161
R43 · FY2020 · NS
DEVELOPMENT OF A WHOLE-BLOOD PLATELET AGGREGOMETER$380,450
R44 · FY2001 · HL
DEVELOPMENT OF A WHOLE-BLOOD PLATELET AGGREGOMETER$368,528
R44 · FY2002 · HL
ALTERNATIVE TO HEPARIN ANTICOAGULATION$288,900
R44 · FY2003 · HL
ANTIMICROBIAL TECHNOLOGY TO ACTIVELY MITIGATE EAR TUBE INFECTIONS LONG TERM$286,288
R43 · FY2019 · DC
POINT-OF-CARE HEMOSTASIS ANALYZER FOR THE INTEGRATED ASSESSMENT OF PLATELET AND COAGULATION FUNCTIONS$223,394
R43 · FY2015 · HL
DEVELOPMENT OF A REVERSIBLE CLOTTING FACTOR FILTER$99,938
R43 · FY2001 · HL
DEVELOPMENT OF A WHOLE-BLOOD PLATELET AGGREGOMETER$96,284
R43 · FY2000 · HL